AcelRx Pharmaceuticals, Inc.

FDA inspection history across 2 sites, 2021

1
Warning letter
1
Close-out

Every document, by year

  • Warning letter
  • Close-out

2021: one warning letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2021One warning letter, at Redwood City, California.

The complete AcelRx Pharmaceuticals file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2021-02-11Warning letter Warning letter$99
UndatedClose-out Close-out letter$99

FEI number 3006386491 · most recent document Feb 11, 2021

About AcelRx Pharmaceuticals, Inc.

Has AcelRx Pharmaceuticals, Inc. received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for AcelRx Pharmaceuticals, Inc.; the most recent is dated Feb 11, 2021.